Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of 12 Months of Therapy With Inhaled Colistimethate Sodium in Subjects With Non-cystic Fibrosis Bronchiectasis Chronically Infected With P. Aeruginosa

NCT03460704 is registered in ClinicalTrials.gov with Zambon SpA as lead sponsor.

NCT NCT03460704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03460704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of 12 Months of Therapy With Inhaled Colistimethate Sodium in Subjects With Non-cystic Fibrosis Bronchiectasis Chronically Infected With P. Aeruginosa
Lead sponsor
Zambon SpA
Phase
Phase 3
Overall status
Terminated
Start date
January 29, 2018
Completion date
March 15, 2022
Enrollment
287 (actual)
Sites
89

Conditions

As the registry lists them; a condition with its own page is linked.

non cystic fibrosis bronchiectasis